1. Xu G, Ding Q, Zhang YF et al. Intravesical instillation of sodium hyaluronate for the treatment of intractable non-bacterial cystitis: a multi-centre study. Presented at the 1st Annual Meeting of MICA, Rome, 21-22 September, 2004.

2. Engelhardt PF, Morakis N, Daha LK et al. Long-term results of intravesical hyaluronan therapy in Bladder Pain Syndrome/Interstitial Cystitis. Int Urogynecol J 2011;22:401-405.

3. Constantinides C, Manousakas T, Nikolopoulos P et al. Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. Br J Urol lnt 2004;93:1262-1266.

4. Delgado Perez JM, Samper P & Garrido JS. Hyaluronic acid in the prevention of radiation-induced cystitis. Proc Am Soc Clin Oncol 2003;22.

5. Meijlink JM. Interstitial Cystitis. Painful Bladder Syndrome, Bladder Pain Syndrome, Hypersensitive Bladder Syndrome Chronic Pelvic Pain. Diagnosis & Treatment. An Overview. International Painful Bladder Foundation. July 2010.

6. Cystistat Instructions For Use.

7. Raymond I, Vasdev N, Ferguson J et al. The clinical effectiveness of intravesical sodium hyaluronate (Cystistat) in patients with interstitial cystitis/painful bladder syndrome and recurrent urinary tract infections. Curr Urol 2012;6:93-98.

8. Teva UK Limited. Data on File. Mylan Global Sales Data. 2017.

9. Kallestrup EB, Jørgensen SS, Nordling J et al. Treatment of interstitial cystitis with Cystistat: A hyaluronic acid product. Scand J Urol Nephrol 2005;39:143-147.

10. Sommariva ML, Sandri SO & Ceriani V. Efficacy of sodium hyaluronate in the management of chemical and radiation cystitis. Minerva Urol Nefrol 2010;62:145-150.

11. Morales A, Emerson L, Nickel JC et al. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 1996;156:45-48.

12. Lipovac M, Kurz C, Reithmayr F et al. Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. lnt J Gynaecol Obstet 2007;96:192-195.

13. Ahmad I, Sarath Krishna N & Meddings RN. Sequential hydrodistension and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. lnt Urogynecol J 2007;19:543-546.

14. Nickel JC, Egerdie B, Downey J et al. A real-life multi-centre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU lnt 2009;103:56-60.

15. Nickel JC, Egerdie RB, Steinhoff G et al. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis/painful bladder syndrome. J Urol 2010;76:804-809.

16. Iavazzo C, Athanasiou S, Pitsouni E et al. Hyaluronic acid: An effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis. Eur Urol 2007;51:1534-1541.

17. Moutzouris DA & Falagas ME. Interstitial cystitis: An unsolved enigma. Clin J Am Soc Nephrol 2009;4:1844-1857.

18. Payne H, Adamson A, Bahl A et al. Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int 2013;112:885-897.

19. Ratliff TL, Klutke CG & McDougall EM. The etiology of interstitial cystitis. Urol Clin North Am 1994;21:21-30.

20. Ho N, Koziol JA & Parsons CL. Epidemiology of interstitial cystitis. In: Sant GR (ed.) Interstitial Cystitis. Philadelphia: Lippincott-Raven;1997:9-16.

21. Hurst RE, Roy JB & Parsons CL. The role of glycosaminoglycans in normal bladder physiology and the pathophysiology of interstitial cystitis. In: Sant GR (ed.) Interstitial Cystitis. Philadelphia: Lippincott-Raven;1997:93-100.

22. Necas J, Bartosikova L, Brauner P, et al. Hyaluronic acid (hyaluronan): a review.Veterinarni Medicina 2008;53:397-411.

23. Hüther H, Mahor S, Carr E, et al. Deciphering the mechanism of hyaluronic acid treatment for interstitial cystitis in an in vitro bladder model. Presented at the 24th European Conference on Biomaterials, September 4th-9th 2011, Dublin, Ireland.

24. Teva UK Ltd. Data on File. Cystistat Product Monograph. 2017.

25. Manas A, Glarfa L, Pena C et al. Prevention of urinary tract infections in palliative radiation for vertebral metastasis and spinal compression: a pilot study in 71 patients. lnt J Radiat Oncol Bioi Phys 2006;64:935-940.